The role of postoperative radiotherapy in node negative breast cancer patients with pT3-T4 disease

European Journal of Surgical Oncology

Volumn 33, Issue 3, 2007, Pages 285-293

  Aksu, G ^a   Kucucuk, S ^b   Fayda, M ^a   Saynak, M ^c   Baskaya, S ^b   Saip, P ^b   Ozturk, N ^b   Aslay, I ^b  

^a KOCAELI UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c TRAKYA UNIVERSITY   (Turkey)

Author keywords

Breast cancer; Locoregional recurrence; Node negative disease; Prognostic factors; Radiotherapy; T3N0

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MASTECTOMY; METASTASIS; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK REDUCTION; THORAX;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MASTECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE PERIOD; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33947680781     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.10.037     Document Type: Article

References (23)

1. Jensen A.R., Garne J.P., Storm H.H., Engholm G., Moller T., and Overgaard J. Does stage at diagnosis explain the difference in survival after breast cancer in Denmark and Sweden?. Acta Oncol 43 8 (2004) 719-726
2. Helintö M., Blomqvist C., Heikkila P., and Joensuu H. Post-mastectomy radiotherapy in pT3N0M0 breast cancer: is it needed?. Radiother Oncol 52 (1999) 213-217
3. Trudeau M.E., Pritchard K.I., Chapman J.A., et al. Prognostic factors affecting the natural history of node-negative breast cancer. Breast Cancer Res Treat 89 (2005) 35-45
4. Fowble B. Postmastectomy radiation: then and now. Oncology 11 (1997) 213-239
5. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 337 (1997) 949-955
6. Ragaz J., Jackson S.M., Le N., et al. Adjuvant radiotherapy and chemotherapy in nodepositive premenopausal women with breast cancer. N Engl J Med 337 (1997) 956-962
7. Fitzgibbons P.L., Page D.L., Weaver D., et al. Prognostic factors in breast cancer: College of American Pathologists consensus statement 1999. Arch Pathol Lab Med 124 (2000) 966-978
8. Fisher B., Bauer M., Wickerham D.L., et al. Relation of the number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer 52 (1983) 1551-1557
9. Haagensen C.D., and Bodian C. A personal experience with Halsted's radical mastectomy. Ann Surg 199 2 (1984) 143-150
10. Fisher B., Wolmark N., Bauer M., Redmond C., and Gebhardt M. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histological nodal status in carcinoma of the breast. Surg Gynecol Obstet 152 (1981) 765-772
11. Cianfrocca M., and Goldstein L.J. Prognostic and predictive factors in early-stage breast cancer. Oncologist 9 (2004) 606-616
12. Carter C.L., Allen C., and Henson D.E. Relation of tumor size, lymph node status and survival in 24,740 breast cancer cases. Cancer 63 (1989) 181-187
13. Rosen P.P., Groshen S., Kinne D.W., and Norton L. Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up. J Clin Oncol 11 (1993) 2090-2100
14. Koscielny S., Tubiana M., Le M.G., et al. Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer 49 (1984) 709-715
15. Grillo M., Jorge M., Vidal M.P., Ortiz M., and Ravasco P. The effect of locoregional recurrence on survival and distant metastasis after conservative treatment for invasive breast carcinoma. Clin Oncol (R Coll Radiol) 17 2 (2005) 111-117
16. Abner A.L., Collins L., Peiro G., et al. Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 carcinoma. Cancer 83 (1998) 2501-2508
17. Donegan W.L., Perez-Mesa C.M., and Watson F.R. A biostatistical study of locally recurrent breast carcinoma. Surg Gynecol Obstet 122 (1966) 529-540
18. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who received adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337 (1997) 949-955
19. Klefstrom P., Grohn P., Heinonen E., Holsti L., and Holsti P. Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer. Cancer 60 (1987) 936-942
20. Quiet C.A., Ferguson D.J., Weichselbaum R.R., and Hellman S. Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up. J Clin Oncol 13 5 (1995) 1144-1151
21. Jagsi R., Raad R.A., Goldberg S., et al. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation. Int J Radiat Oncol Biol Phys 62 4 (2005) 1035-1039
22. Garg A.K., Strom E.A., McNeese M.D., et al. T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy. Int J Radiat Oncol Biol Phys 59 1 (2004) 138-145
23. Gurkaynak M., Yi{dotless}ldi{dotless}z F., and Atahan L. T3N0M0 Breast cancer patients: a subgroup with favorable prognosis. Turk J Cancer 33 3 (2003) 144-149